-

Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science

Multifaceted national initiative invites Americans to share stories of science’s impact and challenge misinformation

ST. LOUIS--(BUSINESS WIRE)--Today, on World Science Day, Bayer is proud to launch its “Science Delivers” campaign, a nationwide initiative celebrating how science delivers answers, hope, and progress for all Americans—every day, in the moments that matter most.

From the medicine that keeps us healthy to the technology that connects and helps feed us, to the innovations that give us hope for the future—science has consistently driven progress and shapes every aspect of our lives. The campaign is inspired by the idea that science delivers more than solutions—it delivers breakthroughs that heal, protect, connect, and empower.

“Science Delivers” comes at a moment when misinformation threatens to undermine America’s innovation drive and the future of such breakthroughs. At a time of uncertainty, Bayer is committed to the idea that science is a method designed to test ideas, challenge assumptions, and build knowledge over time. The campaign encourages scientists, educators, media and citizens to learn how to spot misinformation and help push back against fearmongering and pseudoscience.

The campaign’s features include a Declaration on Science appearing in select newspapers, an interactive website to engage and become part of the movement, ads promoting the campaign, and oversized, interactive “Science, Sealed, Delivered” mailboxes at select events and locations, including most recently at the World Food Prize’s 2025 Borlaug Dialogue in Des Moines, Iowa.

At each mailbox, visitors are invited to scan a QR code and drop a digital postcard, delivering their own science moment— how science has sparked change, inspired hope, or powered progress in their lives and communities. These real stories are showcased on the newly launched ScienceDelivers.com, where Americans can explore a digital mosaic of testimonials, discover how science delivers, and learn more about the scientific process and how to identify credible evidence.

The Declaration on Science – “Don’t (Just) Trust the Science” – appears in the Wall Street Journal, Washington Times and Politico and affirms the importance of an evidence-based process conducted and reviewed by independent sources:

“We must strive to be healthier, more sustainable, and focused on what innovation can bring to improve society. We must celebrate science and continue every day to innovate. To find the next cure. To find the next breakthrough.”

In addition, as part of the campaign, a new video running nationally highlights key innovations made possible by science.

The “Science Delivers” campaign will give Americans a glimpse into scientific milestones that have transformed the way we live, work and care for ourselves and our planet.

Join Us and Share Your Support for Science:

Bayer encourages everyone to engage with the "Science Delivers" campaign by sharing their stories through social media and community events to champion science and its impact. Together, let us recognize the importance of science in our lives and advocate for its vital role in shaping a better future.

For more information on the "Science Delivers" campaign, visit www.ScienceDelivers.com.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to www.bayer.com.

Contacts

Media Contact:
Brian Leake
Brian.Leake@Bayer.com
(314) 370-3285

Bayer

GER:BAYN

Release Versions

Contacts

Media Contact:
Brian Leake
Brian.Leake@Bayer.com
(314) 370-3285

More News From Bayer

Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention

BERLIN--(BUSINESS WIRE)--Bayer today announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian. The study met its primary efficacy and safety endpoints. Asundexian 50 mg once daily significantly reduced the risk of ischemic stroke compared to placebo, both in combination with antiplatelet therapy, in patients after a non-cardioembolic ischemic stroke or high-risk ischemic attack. There was no increase...

U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

WHIPPANY, N.J.--(BUSINESS WIRE)--U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous NSCLC...

Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG

LEVERKUSEN, Germany--(BUSINESS WIRE)--The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial Officer (CFO) on June 1, 2026, following his planned retirement at the end of May 2026. Dr. Hartmann is currently an Operating Partner at Sandbrook Capital, a private investment firm focused on building leading climate infrastructure companies. Previously, she serv...
Back to Newsroom